Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice (Q45867578)

17 December 2017

title

Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice (English)

1 reference

17 December 2017

1 reference

Fu H

1

1 reference

17 December 2017

Kang L

2

1 reference

17 December 2017

Jennings JS

3

1 reference

17 December 2017

Moy SS

4

1 reference

17 December 2017

Perez A

5

1 reference

17 December 2017

Dirosario J

6

1 reference

17 December 2017

McCarty DM

7

1 reference

17 December 2017

Muenzer J

8

1 reference

17 December 2017

publication date

26 April 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

issue

14

1 reference

17 December 2017

page(s)

1065-1077

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302961

exact match

0 references

cites work

Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Enzyme replacement therapy for the mucopolysaccharide storage disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Sanfilippo type B syndrome (mucopolysaccharidosis III B): allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Simulation of hematopoiesis: implications for the gene therapy of lysosomal enzyme disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

The cryptic life style of adeno-associated virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Prevention of neuropathology in the mouse model of Hurler syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Drug and gene delivery to the brain: the vascular route

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood- brain barrier

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Targeted retrograde gene delivery for neuronal protection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Effective gene therapy in an authentic model of Tay-Sachs-related diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Enzyme replacement therapy in alpha-mannosidosis guinea-pigs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Purification and characterization of recombinant human alpha-N-acetylglucosaminidase secreted by Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

The molecular basis of Sanfilippo syndrome type B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

The conjoint importance of the hippocampus and anterior thalamic nuclei for allocentric spatial learning: evidence from a disconnection study in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302961

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302961

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017